Prolacta Bioscience

Duarte, CA, USA Healthcare Acquired

Prolacta Bioscience is a privately held life sciences company dedicated to advancing the science of human milk to provide nutritional products for premature and critically ill infants in neonatal care. The company is the world's leading hospital provider of 100% human milk-based nutritional products, including human milk fortifiers made from donor milk rather than cow milk. Prolacta operates the first and only pharmaceutical-grade manufacturing facility for the processing of human milk, and its products have been used in the care of more than 125,000 premature infants globally. Founded in 1999 and headquartered in Duarte, California, Prolacta was acquired by EW Healthcare Partners in 2024.

Acquired

Prolacta Bioscience has been acquired

Acquired by EW Healthcare Partners 2024

This company is no longer available on our private secondary market.

Overview

Company data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.

Founded

1999

Employees

201–500

Total Funding

$43.91M

2 rounds

Funding

Total raised $43.91M across 2 rounds

Funding data and valuation marks are estimates and may be incomplete, stale, erroneous, or revised.

Last updated 06-25-2026

Latest Round

Type

Series E

Date

May 14, 2018

Amount

$8.91M

Valuation

DateRoundAmount RaisedValuationLead Investors
May 14, 2018 Series E $8.91M
December 6, 2016 Series E / Mezzanine $35M EW Healthcare Partners

Leadership

  • Scott Elster

    Chief Executive Officer

    LinkedIn
  • Scott Eaker

    Chief Operating Officer

  • Melinda Elliott

    Chief Medical Officer

  • Joe Fournell

    Chief Information Officer

  • Martin Lee

    Chief Scientific Officer

Competitors

Competitor list is illustrative and may be incomplete, stale, or erroneous.

  • Medolac Laboratories

    Public benefit corporation founded by ex-Prolacta co-founder Elena Medo in 2009 that produces shelf-stable, donor-derived human milk products for hospitals and outpatient use.

  • Ni-Q

    U.S.-based human milk company providing pasteurized donor human milk and human milk-based fortifiers to NICUs, and a competitor to Prolacta in the donor-milk fortifier market.

  • NeoLacta Lifesciences

    India-based human milk company producing pasteurized donor human milk products and fortifiers for premature and critically ill infants in international NICU markets.

  • BIOMILQ

    Cell-cultured human milk biotechnology startup developing lab-grown human milk components as an alternative to donor milk and infant formula.

Access live market data

Sign Up

Data collected with AI, which can make mistakes. Please double-check this information.